121 related articles for article (PubMed ID: 37742944)
21. Lymphoepithelioma-like hepatocellular carcinoma: Case report and review of the literature.
Cacciato Insilla A; Faviana P; Pollina LE; De Simone P; Coletti L; Filipponi F; Campani D
World J Gastroenterol; 2015 Sep; 21(36):10468-74. PubMed ID: 26420974
[TBL] [Abstract][Full Text] [Related]
22. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Zhang M; Pang HJ; Zhao W; Li YF; Yan LX; Dong ZY; He XF
BMC Cancer; 2018 May; 18(1):511. PubMed ID: 29720116
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.
Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
[TBL] [Abstract][Full Text] [Related]
24. ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma.
Iseda N; Itoh S; Yoshizumi T; Yugawa K; Morinaga A; Tomiyama T; Toshima T; Kohashi K; Oda Y; Mori M
Hepatol Commun; 2021 Apr; 5(4):675-688. PubMed ID: 33860125
[TBL] [Abstract][Full Text] [Related]
25. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
26. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
28. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
29. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1.
Matsuura S; Aishima S; Taguchi K; Asayama Y; Terashi T; Honda H; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):382-90. PubMed ID: 16178893
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
[TBL] [Abstract][Full Text] [Related]
31. LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison With Current LI-RADS Criteria.
Xian MF; Huang Y; Xie WX; Pan KM; Zeng D; Huang H; Li MD; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
AJR Am J Roentgenol; 2022 Jul; 219(1):76-85. PubMed ID: 34910538
[No Abstract] [Full Text] [Related]
32. Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).
Fukuzawa Y; Takahashi K; Furuta K; Tagaya T; Ishikawa T; Wada K; Omoto Y; Koji T; Kakumu S
J Gastroenterol; 2001 Oct; 36(10):681-8. PubMed ID: 11686478
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size.
Wang Q; Luan W; Warren L; Fiel MI; Blank S; Kadri H; Mandeli J; Hiotis SP
J Immunother; 2016 Jan; 39(1):36-44. PubMed ID: 26641260
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
Craciun L; de Wind R; Demetter P; Lucidi V; Bohlok A; Michiels S; Bouazza F; Vouche M; Tancredi I; Verset G; Garaud S; Naveaux C; Galdon MG; Gallo KW; Hendlisz A; Derijckere ID; Flamen P; Larsimont D; Donckier V
BMC Cancer; 2020 Feb; 20(1):135. PubMed ID: 32075608
[TBL] [Abstract][Full Text] [Related]
35. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
[TBL] [Abstract][Full Text] [Related]
36. A tumour-promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways.
Tan H; Wang S; Zhao L
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):213-221. PubMed ID: 27797409
[TBL] [Abstract][Full Text] [Related]
37. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
[TBL] [Abstract][Full Text] [Related]
38. Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma.
Tomiyama T; Itoh S; Iseda N; Toshida K; Morinaga A; Yugawa K; Fujimoto YK; Tomino T; Kurihara T; Nagao Y; Morita K; Harada N; Kohashi K; Oda Y; Mori M; Yoshizumi T
Oncol Lett; 2022 Mar; 23(3):93. PubMed ID: 35154424
[TBL] [Abstract][Full Text] [Related]
39. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma.
Shin E; Ryu HS; Kim SH; Jung H; Jang JJ; Lee K
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):544-50. PubMed ID: 21234611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
